This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Nps Allelix Corporation, Nps Pharmaceuticals, Inc.. Active years: 2001-2014.
Location History:
- Ontario, CA (2006)
- Etobicoke, CA (2001 - 2014)
Company Filing History:
Years Active: 2001-2014
Title: The Innovative Contributions of John Dietrich
Introduction
John Dietrich is a notable inventor based in Etobicoke, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bone resorption diseases. With a total of six patents to his name, Dietrich's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents is a groundbreaking invention related to methods useful in the treatment of bone resorption diseases. This invention involves a combined pharmaceutical preparation that includes parathyroid hormone and a bone resorption inhibitor. The preparation is designed for the administration of parathyroid hormone over a period of approximately six to twenty-four months. Following the termination of parathyroid hormone administration, the bone resorption inhibitor is administered for an additional twelve to thirty-six months. This innovative approach aims to enhance the effectiveness of treatment for patients suffering from bone resorption issues.
Career Highlights
Throughout his career, John Dietrich has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with NPS Allelix Corporation and NPS Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Dietrich has collaborated with several professionals in his field, including Sverker Ljunghall and Sven Sjogren. These collaborations have fostered a productive environment for innovation and have led to the development of effective pharmaceutical solutions.
Conclusion
John Dietrich's contributions to the field of pharmaceuticals, particularly in the treatment of bone resorption diseases, highlight his role as a significant inventor. His innovative patents and collaborations with industry professionals underscore the importance of his work in advancing medical science.